...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Endocyte Valuation

I Was not at the Zenith AGM but during the webcast i thought  i distinctly heard something to the effect that a deal with zenith was suppose to be unveiled at the AGM but was not and Now DM is flying out the Asia that night.  For better or worse something is in the works IMO, whether it is delayed for a better deal or the deal is being worked on, something is happening just a matter of when, IMO, but again we have been hearing this for 10 years so I could be wrong once again  GLTA,  

Share
New Message
Please login to post a reply